Kenichi Harada
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 368 publications
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.
Journal: Annals of hepatology
Published: May 26, 2026
Case Report: Adult-onset diffuse hepatic hemangiomatosis with rapid progression: an autopsy case with diagnostic difficulty.
Journal: Frontiers in medicine
Published: May 25, 2026
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.
Journal: Journal of hepatology
Published: April 24, 2026
Enhanced Peribiliary Gland Detachment in Aged Donor Grafts After Rat Liver Transplantation.
Journal: Transplantation direct
Published: April 22, 2026
Indoleamine 2,3-Dioxygenase 1 as an Adjunctive Histopathological Marker of Cholangitis Activity in Primary Biliary Cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 06, 2026
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.
Journal: Hepatology international
Published: March 31, 2026
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.
Journal: Hepatology (Baltimore, Md.)
Published: March 31, 2026
Metastatic carcinomatous cirrhosis from diffuse breast cancer liver metastasis: a case report.
Journal: Abdominal radiology (New York)
Published: February 16, 2026
Transjugular intrahepatic portosystemic shunt as a feasible option for portal hypertension due to Porto-sinusoidal vascular disorder: a case report.
Journal: Clinical journal of gastroenterology
Published: January 07, 2026
Advanced poorly differentiated gallbladder carcinoma with focal poorly cohesive and signet-ring cell features.
Journal: Clinical journal of gastroenterology
Published: December 13, 2025
Combined administration of interleukin-2 and 18 with anti-PD-L1 antibody induces CCL5-positive CD8 T cells to suppress liver tumors.
Journal: PNAS nexus
Published: December 10, 2025
Last Updated: 09/26/2026